Drug manufacturers, retail pharmacies and regulators have a role to play in curbing antimicrobial resistance say campaigners urging industry to ensure their API suppliers are not part of the problem.
Cefic has agreed to make sure its members only sell the intermediate gamma butyrolactone (GBL) to legitimate users to stop it being abused or used in “date rape” drug GHB.
Boehringer Ingelheim says the biologics plant it opened in Shanghai, China today will cater for customers targeting local and international markets.
Teva Pharmaceuticals has confirmed it intends to sell or close its Gödöllő manufacturing plant by the end of 2018.
Nova DFL’s dental adrenaline product has been denied marketing authorisation after French regulators raised seven critical deficiencies at its facility in Brazil.
CPhI's first ever North American conference is under way. Follow the industry's social media updates live from the event via In-PharmaTechnologist.com
Cambrex Corporation is installing a fourth reactor suite at its High Point, NC-based facility as it continues to grow with its customers in the market, says company VP at CPhI North America.